Cited by 563Neuropeptides and Animal PhysiologyGenetic Associations and EpidemiologyNeurotransmitter Receptor Influence on Behavior

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Allelic Expression Imbalance of Human mu Opioid Receptor (OPRM1) Caused by Variant A118G

Open access

Zhang, Ying, Wang, Danxin, Johnson, Andrew D., Papp, Audrey C., Sadée, Wolfgang·2005·Journal of Biological Chemistry

DOI 10.1074/jbc.m504942200

Open this paper in CoChat — free account

Abstract

As a primary target for opioid drugs and peptides, the mu opioid receptor (OPRM1) plays a key role in pain perception and addiction. Genetic variants of OPRM1 have been implicated in predisposition to drug addiction, in particular the single nucleotide polymorphism A118G, leading to an N40D substitution, with an allele frequency of 10-32%, and uncertain functions. We have measured allele-specific mRNA expression of OPRM1 in human autopsy brain tissues, using A118G as a marker. In 8 heterozygous samples measured, the A118 mRNA allele was 1.5-2.5-fold more abundant than the G118 allele. Transfection into Chinese hamster ovary cells of a cDNA representing only the coding region of OPRM1, carrying adenosine, guanosine, cytidine, and thymidine in position 118, resulted in 1.5-fold lower mRNA levels only for OPRM1-G118, and more than 10-fold lower OPRM1 protein levels, measured by Western blotting and receptor binding assay. After transfection and inhibition of transcription with actinomycin D, analysis of mRNA turnover failed to reveal differences in mRNA stability between A118 and G118 alleles, indicating a defect in transcription or mRNA maturation. These results indicate that OPRM1-G118 is a functional variant with deleterious effects on both mRNA and protein yield. Clarifying the functional relevance of polymorphisms associated with susceptibility to a complex disorder such as drug addiction provides a foundation for clinical association studies.

Integrity signals

Registry

Crossref · 10.1074/jbc.m504942200

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Mfold web server for nucleic acid folding and hybridization prediction
Zuker, M. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg595 · Cited by 13,404
Endogenous Pain Control Systems: Brainstem Spinal Pathways and Endorphin Circuitry
Basbaum, A. I., & Fields, H. L. (1984) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.07.030184.001521 · Cited by 2,687
Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics
Maquat, L. E. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1310 · Cited by 1,214
Single-nucleotide polymorphism in the human mu opioid receptor gene alters β-endorphin binding and activity: Possible implications for opiate addiction
Bond, C. E., LaForge, K. S., Tian, M., Melia, D., Zhang, S., Borg, L., Gong, J., Schluger, J. H., Strong, J. A., Leal, S. M., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9608 · Cited by 1,072
Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor
Duan, J. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg055 · Cited by 931
Evolutionary changes in cis and trans gene regulation
Wittkopp, P. J., Haerum, B. K., & Clark, A. G. (2004) · Nature · doi:10.1038/nature02698 · Cited by 873
Endogenous opioid systems and alcohol addiction
Herz, A. (1997) · Psychopharmacology · doi:10.1007/s002130050169 · Cited by 755
A Functional Polymorphism of the μ-Opioid Receptor Gene is Associated with Naltrexone Response in Alcohol-Dependent Patients
Oslin, D. W., Berrettini, W., Kranzler, H. R., Pettinati, H., Gelernter, J., Volpicelli, J. R., & O'Brien, C. P. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300219 · Cited by 571
Allelic Variation in Gene Expression Is Common in the Human GenomePreprint
Lo, H. S., Wang, Z., Hu, Y., Yang, H. H., Gere, S., Buetow, K. H., & Lee, M. P. (2003) · Genome Research · doi:10.1101/gr.1006603 · Cited by 446
A Haplotype Implicated in Schizophrenia Susceptibility Is Associated with Reduced COMT Expression in Human Brain
Bray, N. J., Buckland, P. R., Williams, N. M., Williams, H. J., Norton, N., Owen, M. J., & O’Donovan, M. C. (2003) · The American Journal of Human Genetics · doi:10.1086/376578 · Cited by 335

Show all 44 references

Research works printed but not linked: 1

Kreek, 1996, Mol. Psychiatry, 1, 232

Sorted by citations

Items 101–200 of 563

Endogenous opiates and behavior: 2005
Bodnar, R. J., & Klein, G. E. (2006) · Peptides · doi:10.1016/j.peptides.2006.07.011 · Cited by 87
Research progress in allele-specific expression and its regulatory mechanisms
Gaur, U., Li, K., Mei, S., & Liu, G. (2013) · Journal of Applied Genetics · doi:10.1007/s13353-013-0148-y · Cited by 88
Relevance of frequent μ-opioid receptor polymorphisms for opioid activity in healthy volunteers
Lötsch, J., & Geißlinger, G. (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500362 · Cited by 85
Identification of aCis-Acting Regulatory Polymorphism in a EucalyptCOBRA-Like Gene Affecting Cellulose Content
Thumma, B. R., Matheson, B. A., Zhang, D., Meeske, C., Meder, R., Downes, G. M., & Southerton, S. G. (2009) · Genetics · doi:10.1534/genetics.109.106591 · Cited by 87
Dopamine and opioid gene variants are associated with increased smoking reward and reinforcement owing to negative mood
Perkins, K. A., Lerman, C. E., Grottenthaler, A., Ciccocioppo, M., Milanak, M. E., Conklin, C. A., Bergen, A. W., & Benowitz, N. L. (2008) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32830c367c · Cited by 84
OPRM1 Asn40Asp Predicts Response to Naltrexone Treatment: A Haplotype‐Based Approach
Oroszi, G., Anton, R. F., O’Malley, S. S., Swift, R. M., Pettinati, H. M., Couper, D. J., Yuan, Q., & Goldman, D. A. (2008) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00846.x · Cited by 87
Endogenous opioid system influences depressive reactions to socially painful targeted rejection life events
Slavich, G. M., Tartter, M. A., Brennan, P. A., & Hammen, C. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.07.009 · Cited by 83
Can extremely low or high morphine formation from codeine be predicted prior to therapy initiation?
Lötsch, J., Rohrbacher, M., Schmidt, H., Doehring, A., Brockmöller, J., & Geißlinger, G. (2009) · Pain · doi:10.1016/j.pain.2009.03.023 · Cited by 83
Stress-Induced and Cue-Induced Craving for Alcohol in Heavy Drinkers: Preliminary Evidence of Genetic Moderation by the OPRM1 and CRH-BP Genes
Ray, L. A. (2010) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2010.01333.x · Cited by 83
The Role of the Asn40Asp Polymorphism of the Mu Opioid Receptor Gene (OPRM1) on Alcoholism Etiology and Treatment: A Critical Review
Ray, L. A., Barr, C. S., Blendy, J. A., Oslin, D. W., Goldman, D. A., & Anton, R. F. (2011) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2011.01633.x · Cited by 81
Association of human μ‐opioid receptor gene polymorphism A118G with fentanyl analgesia consumption in Chinese gynaecological patients
Zhang, W., Chang, Y.-S., Kan, Q., Zhang, L. R., Lu, H., Chu, Q., Wang, Z., Li, Z., & Zhang, J. (2009) · Anaesthesia · doi:10.1111/j.1365-2044.2009.06193.x · Cited by 80
Pharmacogenomics of the RNA World: Structural RNA Polymorphisms in Drug Therapy
Sadée, W., Wang, D., Papp, A. C., Pinsonneault, J. K., Smith, R. M., Moyer, R. A., & Johnson, A. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.314 · Cited by 79
Self-citation
Association of the mu-opioid receptor gene with smoking cessation
Munafò, M. R., Elliot, K. M., Murphy, M. F. G., Walton, R. T., & Johnstone, E. C. (2007) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500432 · Cited by 78
A Functional Haplotype Implicated in Vulnerability to Develop Cocaine Dependence is Associated with Reduced PDYN Expression in Human Brain
Yuferov, V. P., Ji, F., Nielsen, D. A., Levran, O., Ho, A., Morgello, S., Shi, R., Ott, J., & Kreek, M. J. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.187 · Cited by 74
Now or Later? An fMRI study of the effects of endogenous opioid blockade on a decision-making network
Boettiger, C. A., Kelley, E. A., Mitchell, J., D’Esposito, M., & Fields, H. L. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.02.008 · Cited by 82
Genetic variability at COMT but not at OPRM1 and UGT2B7 loci modulates morphine analgesic response in acute postoperative pain
Gregori, M. D., Garbin, G., Gregori, S. D., Minella, C. E., Bugada, D., Lisa, A., Govoni, S. M., Regazzi, M. B., Allegri, M., & Ranzani, G. N. (2013) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-013-1523-7 · Cited by 76
Subjective Response to Alcohol Among Alcohol‐Dependent Individuals: Effects of the Mu‐Opioid Receptor (OPRM1) Gene and Alcoholism Severity
Ray, L. A., Bujarski, S., MacKillop, J., Courtney, K. E., Monti, P. M., & Miotto, K. (2013) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2012.01916.x · Cited by 75
In vitro assays fail to predict in vivo effects of regulatory polymorphisms
Cirulli, E. T., & Goldstein, D. B. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm140 · Cited by 75
Behavioural activation system sensitivity is associated with cerebral μ-opioid receptor availability
Karjalainen, T., Tuominen, L. J., Manninen, S., Kalliokoski, K. K., Nuutila, P., Jääskeläinen, I. P., Hari, R., Sams, M. E., & Nummenmaa, L. (2016) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsw044 · Cited by 76
KCNMB1 genotype influences response to verapamil SR and adverse outcomes in the INternational VErapamil SR/Trandolapril STudy (INVEST)
Beitelshees, A. L., Gong, Y., Wang, D., Schork, N. J., Cooper‐DeHoff, R. M., Langaee, T. Y., Shriver, M. D., Sadée, W., Knot, H. J., Pepine, C. J., et al. (2007) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32810f2e3c · Cited by 73
Self-citation
Molecular Imaging of Opioid and Dopamine Systems: Insights Into the Pharmacogenetics of Opioid Use Disorders
Burns, J. A., Kroll, D. S., Feldman, D. E., Liu, C. K., Manza, P., Wiers, C. E., Volkow, N. D., & Wang, G. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00626 · Cited by 75
Association between KCNJ6 (GIRK2) Gene Polymorphisms and Postoperative Analgesic Requirements after Major Abdominal Surgery
Nishizawa, D., Nagashima, M., Katoh, R., Satoh, Y., Tagami, M., Kasai, S., Ogai, Y., Han, W., Hasegawa, J., Shimoyama, N., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007060 · Cited by 71
Missing heritability of common diseases and treatments outside the protein-coding exome
Sadée, W., Hartmann, K., Seweryn, M. T., Pietrzak, M., Handelman, S. K., & Rempała, G. A. (2014) · Human Genetics · doi:10.1007/s00439-014-1476-7 · Cited by 74
Self-citation
Effects of Opioid Receptor Gene Variation on Targeted Nalmefene Treatment in Heavy Drinkers
Arias, A. J., Armeli, S., Gelernter, J. E., Covault, J., Kallio, A., Karhuvaara, S., Koivisto, T., Mäkelä, R., & Kranzler, H. R. (2008) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00735.x · Cited by 71
Functional characterization of human variants of the mu-opioid receptor gene
Ravindranathan, A., Joslyn, G., Robertson, M. A., Schuckit, M. A., Whistler, J. L., & White, R. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904509106 · Cited by 71
Pharmacogenetics of Naltrexone in Asian Americans: A Randomized Placebo-Controlled Laboratory Study
Ray, L. A., Bujarski, S., Chin, P. F., & Miotto, K. A. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.192 · Cited by 71
Cis-Expression Quantitative Trait Loci Mapping Reveals Replicable Associations with Heroin Addiction in OPRM1
Hancock, D. B., Levy, J. L., Gaddis, N., Glasheen, C., Saccone, N. L., Page, G. P., Hulse, G. K., Wildenauer, D., Kelty, E. A., Schwab, S. G., et al. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.01.003 · Cited by 71
Association Between Human Pain‐Related Genotypes and Variability in Opioid Analgesia: An Updated Review
Nielsen, L. M., Olesen, A. E., Branford, R., Christrup, L. L., Sato, H., & Drewes, A. M. (2014) · Pain Practice · doi:10.1111/papr.12232 · Cited by 70
Influence of OPRM1 Asn40Asp variant (A118G) on [11C]carfentanil binding potential: preliminary findings in human subjects
Weerts, E. M., McCaul, M. E., Kuwabara, H., Yang, X., Xu, X., Dannals, R. F., Frost, J. J., Wong, D. F., & Wand, G. S. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114571200017x · Cited by 69
Current evidence for a modulation of low back pain by human genetic variants
Tegeder, I., & Lötsch, J. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00703.x · Cited by 69
Pharmacogenetic Treatments for Drug Addiction: Alcohol and Opiates
Haile, C. N., Kosten, T. A., & Kosten, T. R. (2008) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990802122564 · Cited by 73
Alcohol Addiction: A Molecular Biology Perspective
Ferraguti, G., Pascale, E., & Lucarelli, M. (2015) · Current Medicinal Chemistry · doi:10.2174/0929867321666141229103158 · Cited by 66
Genetic influences on the dynamics of pain and affect in fibromyalgia.
Finan, P. H., Zautra, A., Davis, M. C., Lemery‐Chalfant, K., Covault, J., & Tennen, H. A. (2010) · Health Psychology · doi:10.1037/a0018647 · Cited by 67
Single nucleotide polymorphisms of the DNA repair gene XPD/ERCC2 alter mRNA expression
Wolfe, K. J., Wickliffe, J. K., Hill, C. E., Paolini, M., Ammenheuser, M. M., & Abdel‐Rahman, S. Z. (2007) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3280115e63 · Cited by 65
REVIEW: Targeting treatments for alcohol dependence: the pharmacogenetics of naltrexone
Oslin, D. W., Berrettini, W. H., & O’Brien, C. P. (2006) · Addiction Biology · doi:10.1111/j.1369-1600.2006.00036.x · Cited by 67
Pain tolerance predicts human social network size
Johnson, K. V.-A., & Dunbar, R. I. M. (2016) · Scientific Reports · doi:10.1038/srep25267 · Cited by 65
Whole transcriptome RNA-Seq allelic expression in human brain
Smith, R. M., Webb, A., Papp, A. C., Newman, L. C., Handelman, S. K., Suhy, A., Mascarenhas, R., Oberdick, J., & Sadée, W. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-571 · Cited by 67
Self-citation
Association Between Single Nucleotide Polymorphisms in the Cannabinoid Receptor Gene (CNR1) and Impulsivity in Southwest California Indians
Ehlers, C. L., Slutske, W. S., Lind, P. A., & Wilhelmsen, K. C. (2007) · Twin Research and Human Genetics · doi:10.1375/twin.10.6.805 · Cited by 65
A Review of the Role of Genetic Testing in Pain Medicine
Trescot, A. M. (2014) · Pain Physician · doi:10.36076/ppj.2014/17/425 · Cited by 65
Low μ-Opioid Receptor Status in Alcohol Dependence Identified by Combined Positron Emission Tomography and Post-Mortem Brain Analysis
Hermann, D., Hirth, N., Reimold, M., Batra, A., Smolka, M. N., Hoffmann, S., Kiefer, F., Noori, H. R., Sommer, W. H., Reischl, G., et al. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.145 · Cited by 64
Ethnic-specific meta-analyses of association between the OPRM1 A118G polymorphism and alcohol dependence among Asians and Caucasians
Chen, D., Liu, L., Xiao, Y., Peng, Y., Yang, C., & Wang, Z. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.10.012 · Cited by 64
Association of Mu-Opioid Receptor Variants and Response to Citalopram Treatment in Major Depressive Disorder
Garriock, H. A., Tanowitz, M., Kraft, J. B., Dang, V. C., Peters, E. J., Jenkins, G. D., Reinalda, M. S., McGrath, P. J., von Zastrow, M., Slager, S. L., et al. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.08081167 · Cited by 64
Initial Evidence of an Association Between OPRM1 and Adolescent Alcohol Misuse
Miranda, R., Ray, L. A., Justus, A. N., Meyerson, L. A., Knopik, V. S., McGeary, J. E., & Monti, P. M. (2009) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2009.01073.x · Cited by 65
Recent Developments in the Study of Opioid Receptors
Cox, B. M. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.083279 · Cited by 64
Effect of μ-Opioid Receptor Gene Polymorphisms on Heroin-Induced Subjective Responses in a Chinese Population
Zhang, D., Shao, C., Shao, M., Yan, P., Wang, Y., Liu, Y., Liu, W., Lin, T., Xie, Y., Zhao, Y., et al. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.07.012 · Cited by 63
Pharmacogenetics of Alcohol and Alcohol Dependence Treatment
Kranzler, H. R., & Edenberg, H. J. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210791516387 · Cited by 64
A Clinical Genetic Method to Identify Mechanisms by Which Pain Causes Depression and Anxiety
Max, M. B., Wu, T., Atlas, S. J., Edwards, R. R., Haythornthwaite, J. A., Bollettino, A. F., Hipp, H. S., McKnight, C. D., Osman, I. A., Crawford, E. N., et al. (2006) · Molecular Pain · doi:10.1186/1744-8069-2-14 · Cited by 62
Pharmacological Consequence of the A118G μ Opioid Receptor Polymorphism on Morphine- and Fentanyl-mediated Modulation of Ca2+Channels in Humanized Mouse Sensory Neurons
Mahmoud, S., Thorsell, A., Sommer, W. H., Heilig, M. A., Holgate, J. K., Bartlett, S. E., & Ruiz-Velasco, V. (2011) · Anesthesiology · doi:10.1097/aln.0b013e318231fc11 · Cited by 62
Mouse Model of the OPRM1 (A118G) Polymorphism: Differential Heroin Self-Administration Behavior Compared with Wild-Type Mice
Zhang, Y., Picetti, R., Butelman, E. R., Ho, A., Blendy, J. A., & Kreek, M. J. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.286 · Cited by 61
Self-citation
Pharmacogenomics of the Human µ-Opioid Receptor
Kasai, S., & Ikeda, K. (2011) · Pharmacogenomics · doi:10.2217/pgs.11.68 · Cited by 61
Post-translational Modifications of Opioid Receptors
Duarte, M. L., & Devi, L. A. (2020) · Trends in Neurosciences · doi:10.1016/j.tins.2020.03.011 · Cited by 61
Population-specific effects of the Asn40Asp polymorphism at the μ-opioid receptor gene (OPRM1) on HPA-axis activation
Hernández–Ávila, C. A., Covault, J., Wand, G. S., Zhang, H., Gelernter, J. E., & Kranzler, H. R. (2007) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3282f0b99c · Cited by 59
OPRM1 and CYP2B6 Gene Variants as Risk Factors in Methadone-Related Deaths
Bunten, H., Liang, W. J., Pounder, D. J., Seneviratne, C. K., & Osselton, D. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.127 · Cited by 58
Current evidence for a modulation of nociception by human genetic polymorphisms
Lötsch, J., & Geißlinger, G. (2007) · Pain · doi:10.1016/j.pain.2007.06.024 · Cited by 58
A Pharmacogenetic Determinant of Mu-Opioid Receptor Antagonist Effects on Alcohol Reward and Consumption: Evidence from Humanized Mice
Bilbao, A., Robinson, J. E., Heilig, M. A., Malanga, C. J., Spanagel, R., Sommer, W. H., & Thorsell, A. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.08.021 · Cited by 59
Influence of Mu-Opioid Receptor Variant on Morphine Use and Self-Rated Pain Following Abdominal Hysterectomy
Sia, A. T. H., Lim, Y., Lim, E. C. P., Ocampo, C. E., Lim, W.-Y., Cheong, P., & Tan, E. (2013) · Journal of Pain · doi:10.1016/j.jpain.2013.03.008 · Cited by 58
Targeting Endogenous Mu- and Delta-Opioid Receptor Systems for the Treatment of Drug Addiction
Shippenberg, T. S., LeFevour, A., & Chefer, V. I. (2008) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152708786927813 · Cited by 58
OPRM1 and COMT Gene–Gene Interaction Is Associated With Postoperative Pain and Opioid Consumption After Orthopedic Trauma
Khalil, H., Sereika, S. M., Dai, F., Alexander, S. A., Conley, Y. P., Gruen, G. S., Li, M., Siska, P. A., Tarkin, I. S., & Henker, R. (2016) · Biological Research For Nursing · doi:10.1177/1099800416680474 · Cited by 58
Delta and kappa opioid receptor polymorphisms influence the effects of naltrexone on subjective responses to alcohol
Ashenhurst, J. R., Bujarski, S., & Ray, L. A. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.08.019 · Cited by 57
Pharmacogenomic considerations in opioid analgesia
Landau, R. (2012) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s23422 · Cited by 57
Common and specific liability to addiction: Approaches to association studies of opioid addiction
Nielsen, D. A., & Kreek, M. J. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.03.026 · Cited by 55
CYP2D6 Polymorphisms and Codeine Analgesia in Postpartum Pain Management: A Pilot Study
vanderVaart, S., Berger, H. M., Sistonen, J., Madadi, P., Matok, I., Gijsen, V. M. G. J., de Wildt, S. N., Taddio, A., Ross, C. J., Carleton, B., et al. (2011) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e3182272b10 · Cited by 56
The Role of Hydromorphone and OPRM1 in Postoperative Pain Relief with Hydrocodone
Jortani, S. A. (2013) · Pain Physician · doi:10.36076/ppj.2013/16/e227 · Cited by 55
Polymorphism of the μ-Opioid Receptor Gene (OPRM1 118A>G) Affects Fentanyl-Induced Analgesia During Anesthesia and Recovery
Wu, W. D., Wang, Y., Fang, Y., & Zhou, H. (2009) · Molecular Diagnosis & Therapy · doi:10.1007/bf03256337 · Cited by 55
Cortisol Stress Response in Men and Women Modulated Differentially by the Mu-Opioid Receptor Gene Polymorphism OPRM1 A118G
Lovallo, W. R., Enoch, M., Acheson, A., Cohoon, A. J., Sorocco, K. H., Hodgkinson, C. A., Vincent, A. S., Glahn, D. C., & Goldman, D. A. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.101 · Cited by 54
A Heroin Addiction Severity-Associated Intronic Single Nucleotide Polymorphism Modulates Alternative Pre-mRNA Splicing of the Opioid Receptor Gene OPRM1 via hnRNPH Interactions
Xu, J., Lu, Z., Xu, M., Pan, L., Deng, Y., Xie, X., Liu, H., Ding, S., Hurd, Y. L., Pasternak, G. W., et al. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.3986-13.2014 · Cited by 55
Cannabinoid Receptor Type 1 and mu-Opioid Receptor Polymorphisms Are Associated With Cyclic Vomiting Syndrome
Wasilewski, A., Lewandowska, U., Mosińska, P., Watała, C. W., Storr, M., Fichna, J., & Venkatesan, T. (2017) · The American Journal of Gastroenterology · doi:10.1038/ajg.2017.73 · Cited by 55
Human N-acetyltransferase 1 *10 and *11 alleles increase protein expression through distinct mechanisms and associate with sulfamethoxazole-induced hypersensitivity
Wang, D., Para, M. F., Koletar, S. L., & Sadee, W. (2011) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3283498ee9 · Cited by 53
Self-citation
Association between single nucleotide polymorphisms in the mu opioid receptor gene (OPRM1) and self-reported responses to alcohol in American Indians
Ehlers, C. L., Lind, P. A., & Wilhelmsen, K. C. (2008) · BMC Medical Genetics · doi:10.1186/1471-2350-9-35 · Cited by 53
Modulation of Ca2+ Channels by Heterologously Expressed Wild-Type and Mutant Human μ-Opioid Receptors (hMORs) Containing the A118G Single-Nucleotide Polymorphism
Margas, W., Zubkoff, I., Schuler, H. G., Janicki, P. K., & Ruiz-Velasco, V. (2006) · Journal of Neurophysiology · doi:10.1152/jn.01007.2006 · Cited by 52
Reduced expression of the mu opioid receptor in some, but not all, brain regions in mice with OPRM1 A112G
Wang, Y.-J., Huang, P., Ung, A., Blendy, J. A., & Liu‐Chen, L. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2011.12.033 · Cited by 51
The pharmacogenomics of pain management: prospects for personalized medicine
Schug, S. A., & Ting, S. (2016) · Journal of Pain Research · doi:10.2147/jpr.s55595 · Cited by 51
OPRM1 gene variants modulate amphetamine-induced euphoria in humans
Dlugos, A. M., Hamidovic, A., Hodgkinson, C. A., Shen, P., Goldman, D. A., Palmer, A. A., & de Wit, H. (2010) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2010.00655.x · Cited by 49
Initial Evidence that OPRM1 Genotype Moderates Ventral and Dorsal Striatum Functional Connectivity During Alcohol Cues
Ray, L. A., Courtney, K. E., Hutchison, K. E., MacKillop, J., Galván, A., & Ghahremani, D. G. (2013) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12136 · Cited by 52
When the Safe Alternative Is Not That Safe: Tramadol Prescribing in Children
Rodieux, F., Vutskits, L., Posfay-Barbe, K. M., Habre, W., Piguet, V., Desmeules, J. A., & Samer, C. F. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00148 · Cited by 49
Association of OPRM1 A118G variant with risk of morphine-induced respiratory depression following spine fusion in adolescents
Chidambaran, V., Mavi, J., Esslinger, H. R., Pilipenko, V. V., Martin, L. J., Zhang, K., & Sadhasivam, S. (2014) · The Pharmacogenomics Journal · doi:10.1038/tpj.2014.59 · Cited by 47
Influence of candidate polymorphisms on the dipeptidyl peptidase IV and μ-opioid receptor genes expression in aspect of the β-casomorphin-7 modulation functions in autism
Cieślińska, A., Sienkiewicz‐Szłapka, E., Wasilewska, J., Fiedorowicz, E., Chwała, B., Moszyńska, M., Cieśliński, T., Bukało, M., & Kostyra, E. (2015) · Peptides · doi:10.1016/j.peptides.2014.11.012 · Cited by 48
OPRM1 rs1799971, COMT rs4680, and FAAH rs324420 genes interact with placebo procedures to induce hypoalgesia
Colloca, L., Wang, Y., Martinez, P. E., Chang, Y.-P. C., Ryan, K. A., Hodgkinson, C. A., Goldman, D. A., & Dorsey, S. G. (2019) · Pain · doi:10.1097/j.pain.0000000000001578 · Cited by 49
Pharmacogenetics: a tool for identifying genetic factors in drug dependence and response to treatment.
Mroziewicz, M., & Tyndale, R. F. (2010) · PubMed Central · Cited by 47
Pharmacogenomics of Methadone Maintenance Treatment
Somogyi, A. A., Barratt, D. T., Ali, R. L., & Coller, J. K. (2014) · Pharmacogenomics · doi:10.2217/pgs.14.56 · Cited by 47
Combined analysis of circulating β-endorphin with gene polymorphisms in OPRM1, CACNAD2 and ABCB1 reveals correlation with pain, opioid sensitivity and opioid-related side effects
Rhodin, A., Grönbladh, A., Ginya, H., Nilsson, K. W., Rosenblad, A., Zhou, Q., Enlund, M., Hallberg, M., Gordh, T., & Nyberg, F. (2013) · Molecular Brain · doi:10.1186/1756-6606-6-8 · Cited by 47
Opioidergic Regulation of Emotional Arousal: A Combined PET–fMRI Study
Karjalainen, T., Seppälä, K., Glerean, E., Karlsson, H. K., Lahnakoski, J. M., Nuutila, P., Jääskeläinen, I. P., Hari, R., Sams, M. E., & Nummenmaa, L. (2018) · Cerebral Cortex · doi:10.1093/cercor/bhy281 · Cited by 46
Potential biomarkers for persistent and neuropathic pain therapy
Sisignano, M., Lötsch, J., Parnham, M. J., & Geißlinger, G. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.02.004 · Cited by 44
Genetics of Opiate Addiction
Reed, B., Butelman, E. R., Yuferov, V. P., Randesi, M., & Kreek, M. J. (2014) · Current Psychiatry Reports · doi:10.1007/s11920-014-0504-6 · Cited by 51
The μ‐opioid receptor gene A118G polymorphism is associated with insecure attachment in children with disruptive mood regulation disorder and their mothers
Cimino, S., Carola, V., Cerniglia, L., Bussone, S., Bevilacqua, A., & Tambelli, R. (2020) · Brain and Behavior · doi:10.1002/brb3.1659 · Cited by 46
Pharmacogenetics of opioids: a narrative review
Kumar, S., Kundra, P., Ramsamy, K., & Surendiran, A. (2019) · Anaesthesia · doi:10.1111/anae.14813 · Cited by 45
ELK1 Transcription Factor Linked to Dysregulated Striatal Mu Opioid Receptor Signaling Network and OPRM1 Polymorphism in Human Heroin Abusers
Daws, S. E., Whittard, J. D., Jacobs, M. M., Ren, Y., Mazloom, A. R., Caputi, F. F., Horváth, M., Keller, É., Ma’ayan, A., Pan, Y., et al. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.04.012 · Cited by 45
Tobacco smoking produces greater striatal dopamine release in G-allele carriers with mu opioid receptor A118G polymorphism
Domino, E. F., Evans, C., Ni, L., Guthrie, S. K., Koeppe, R. A., & Zubieta, J. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.04.003 · Cited by 43
Immune Response Activation and Immunomodulation
Tyagi, R. K., & Bisen, P. S. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.73708 · Cited by 44
Advances in Medications and Tailoring Treatment for Alcohol Use Disorder
Seneviratne, C. (2015) · Alcohol research · doi:10.35946/arcr.v37.1.02 · Cited by 42
Nicotine abstinence-induced cerebral blood flow changes by genotype
Wang, Z., Ray, R., Faith, M. S., Tang, K. Z., Wileyto, E. P., Detre, J. A., & Lerman, C. E. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.04.084 · Cited by 42
Pharmacogenetics of smoking cessation therapy
Kortmann, G. L., Dobler, C. J., Bizarro, L., & Bau, C. H. D. (2009) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30978 · Cited by 41
The µ-Opioid Receptor and Treatment Response to Naltrexone
Thorsell, A. (2013) · Alcohol and Alcoholism · doi:10.1093/alcalc/agt030 · Cited by 43
Codeine-related deaths: The role of pharmacogenetics and drug interactions
Lam, J., Woodall, K. L., Solbeck, P., Ross, C. J., Carleton, B., Hayden, M. R., Koren, G., & Madadi, P. (2014) · Forensic Science International · doi:10.1016/j.forsciint.2014.03.018 · Cited by 42
The OPRM1 A118G polymorphism modulates the descending pain modulatory system for individual pain experience in young women with primary dysmenorrhea
Wei, S., Chen, L., Lin, M., Li, W., Low, I., Yang, C., Chao, H., & Hsieh, J. (2017) · Scientific Reports · doi:10.1038/srep39906 · Cited by 43
Pharmacogenetics of Opiates in Clinical Practice: the Visible Tip of the Iceberg
Hajj, A., Khabbaz, L. R., Laplanche, J., & Peoc’h, K. (2013) · Pharmacogenomics · doi:10.2217/pgs.13.13 · Cited by 40
Allele-Specific Expression of APC in Adenomatous Polyposis Families
Castellsagué, E., González, S., Guinó, E., Purrington, K. S., Borràs, E., Raymond, V. M., Lázaro, C., Blanco, I., Gruber, S. B., & Capellá, G. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.04.047 · Cited by 38
Addiction associated N40D mu-opioid receptor variant modulates synaptic function in human neurons
Halikere, A., Popova, D., Scarnati, M. S., Hamod, A., Swerdel, M. R., Moore, J. C., Tischfield, J. A., Hart, R. P., & Pang, Z. P. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0507-0 · Cited by 37
The effect of alcohol priming on neural markers of alcohol cue-reactivity
Courtney, K. E., Ghahremani, D. G., & Ray, L. A. (2015) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2015.1044608 · Cited by 41
Low frequency genetic variants in the μ-opioid receptor (OPRM1) affect risk for addiction to heroin and cocaine
Clarke, T., Crist, R. C., Kampman, K. M., Dackis, C. A., Pettinati, H. M., O’Brien, C. P., Oslin, D. W., Ferraro, T. N., Lohoff, F. W., & Berrettini, W. H. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.02.018 · Cited by 40

Authors: Zhang, Y., Wang, D., Johnson, A. D., Papp, A. C., & Sadée, W.
Affiliations: The Ohio State University (US)
Corresponding author: Sadée, Wolfgang
ORCID: Zhang, Ying
Johnson, Andrew D.
Sadée, Wolfgang
Venue: Journal of Biological Chemistry
Publisher: Elsevier BV
Published: 2005-09
Volume: 280
Issue: 38
Pages: 32618-32624
ISSN: 0021-9258 (ISSN-L)
DOI: 10.1074/jbc.m504942200
OpenAlex: W1996783118
Cited by: 563
References: 44
Citations by year: 2026: 5 · 2025: 7 · 2024: 9 · 2023: 11 · 2022: 27 · 2021: 14 · 2020: 21 · 2019: 24 · 2018: 24 · 2017: 26 · 2016: 22 · 2015: 41 · 2014: 39 · 2013: 37 · 2012: 46
FWCI: 12.94
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
creativecommons.org/licenses/by/4.0/ (vor, 5512 d)
Locations: Journal of Biological Chemistry (publishedVersion, cc-by)
PubMed (publishedVersion)
Funders: National Institute on Drug Abuse (DA018744, R21DA018744)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords: mu-opioid receptor, OPRM1, A118G polymorphism, gene dosage imbalance, mRNA stability, transcriptional defects, receptor expression, human brain tissue
MeSH terms: Alleles, Animals, Brain, Cell Line, Dactinomycin, DNA, Gene Frequency, Genotype, Cricetinae, Heterozygote, Humans, Nucleic Acid Conformation, Plasmids, Polymorphism, Genetic, RNA, Messenger, Time Factors, Transcription, Genetic, Transfection, Genetic Variation, Blotting, Western, Mutagenesis, Mutagenesis, Site-Directed, CHO Cells, Receptors, Opioid, mu, DNA, Complementary, Nucleic Acid Synthesis Inhibitors, Substance-Related Disorders, Genetic Predisposition to Disease, Reverse Transcriptase Polymerase Chain Reaction, Polymorphism, Single Nucleotide, Allelic Imbalance

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Allelic Expression Imbalance of Human mu Opioid Receptor (OPRM1) Caused by Variant A118G

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks